Supplemental Resident Infection Form

Att. F1 - Supplemental_Resident Infection Form.docx

Survey of Healthcare-Associated Infections and Antimicrobial Use in U.S. Nursing Homes for use in Exploring the Development of a National Prevalence Model

Supplemental Resident Infection Form

OMB: 0920-1165

Document [docx]
Download: docx | pdf

Resident ID: ___-___-_____


Nursing Home Prevalence Survey: Resident Infection From


Survey Date: // Date Form Completed: // Data Collected by: _____ (initials)


For local use only, will not be Transmitted to CDC


Resident Name:__________________________________ Medical Record Number: ___________________






This form is being completed because the resident (check one):

was receiving

systemic antimicrobials

had condition that may

indicate infection

The date of interest is:

Antimicrobial start date:

/ /

Prevalence survey date:

/ /

The time period of interest for chart review begins:

7 days before the antimicrobial start date, beginning on

/ /

7 days before the survey date,

beginning on

/ /



Date of first sign or symptom onset: / /


First sign or symptom onset occurred while resident was in: This facility Prior to admission


Section A: Constitutional signs and symptoms: CHECK ALL THAT APPLY

Check here if after your review NO constitutional signs or symptoms are documented


Acute change in mental status from baseline

WERE ANY OF THE FOLLOWING DOCUMENTED:

Fluctuating: Behavior fluctuating (e.g., coming and

Going, or change in severity during assessment)

Inattention: Difficulty focusing attention ( e.g., unable to keep

track of discussion or easily distracted)

Disorganized thinking: Thinking is incoherent (e.g., rambling

conversation, unclear flow of ideas, unpredictable switched

in subject)

Altered consciousness: Level described as different from

baseline (Hyperalert, sleepy, drowsy, difficult to arouse,

nonresponsive)

Confusion

Other , please specify:______________________________



Acute functional decline: increase in assistance with activities of

daily living (ADL) from baseline

WAS AN INCREASES IN LEVEL OF ASSISTANCE REQUIRED FOR ANY OF THE FOLLOWING DOCUMENTED:

Bed mobility

Transfer

Locomotion within the facility

Dressing

Toilet use

Personal hygiene

Eating



Rigors or chills


Myalgias or body aches

Malaise


Loss of appetite or decreased oral intake


New-onset hypotension


Respiratory rate >=25 breaths per minute


Decreased oxygenation

Select which of the following were documented:

Pulse oximetry with single O2 saturation reading of <94%

Pulse oximetry with single O2 saturation reading showing

reduction of 3% from baseline

Resident newly placed on oxygen


Leukocytosis

Select which of the following were documented:

Neutrophilia (>14,000 leukocytes/mm3)

Left shift (6% bands or ≥1,500 bands/mm3)

Fever

SELECT WHICH OF THE FOLLOWING WERE DOCUMENTED:

Single temperature >37.8oC (>100oF)

Repeated temperatures >37.2oC (99oF)

Single temperature >1.1oC (2oF) over baseline

Term “Fever” is documented, but temperature value is

not recorded


New hypothermia (<34.5oC, or does not register on the thermometer being used)






Section B: Urinary tract infection signs, symptoms, or tests

Check here if after your review NO urinary tract signs, symptoms or tests are documented

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):


LOCALIZING URINARY SIGNS OR SYMPTOMS


Acute dysuria (e.g., “burning or pain with urination”)

Gross hematuria

Acute pain/swelling or tenderness of the testes,

epididymis, or prostate

New or marked increase in frequency


Purulent discharge around catheter

New or marked increase in urgency

Acute costovertebral angle pain or tenderness

New or marked increase in incontinence

Suprapubic pain or tenderness



INDWELLING URINARY CATHETER status at the time of urinary sign/symptom onset:

Resident without an indwelling urinary catheter Resident with an indwelling urinary catheter


URINALYSIS (U/A or Urine Test or Urine Analysis)

Was a urinalysis performed

Yes No

If yes, date performed:

//

If yes, record the following results

Positive

Negative

Not done

Nitrites:

Leukocyte esterase:

>5 White blood cells:


URINE CULTURE

Was a urine collected for culture:

Yes No

If yes, date of specimen collection:

//

How the specimen was collected:

Voided urine sample

Indwelling urinary catheter specimen

Straight (“In-and-out”) catheter

Other………………………………………….

Not documented

Urine culture result:

Positive Negative (no growth) Result not available

If positive, report the organisms isolated from this specimen


Organism name: Use Codes List

Number Colony forming units (CFU)/mL

1



2



3




This resident had documentation of provider suspected or diagnosed urinary tract infection



Enter any additional comments or information related to urinary tract signs, symptoms or tests:


















Section C: Respiratory tract infection signs, symptoms or tests

Check here if after your review NO respiratory tract signs, symptoms or tests are documented

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

RESPIRATORY SIGNS AND SYMPTOMS


Runny nose or sneezing

New / increased cough

Stuff nose (i.e. congestion)

New/increased sputum production

Sore throat or hoarseness or difficulty swallowing

Pleuritic chest pain

Headache or eye pain

Abnormal lung examination (new or changed)

Swollen or tender glands in the neck (cervical lymphadenopathy)



RESPIRATORY X-RAY IMAGINING

Was X-RAY imaging performed

Yes No

If yes, date performed:

//

If yes, record the x-ray findings


X-ray findings not available

Negative x-ray findings

POSITIVE for pneumonia or a new infiltrate

POSITIVE with findings not consistent with pneumonia or a new infiltrate

Other findings, specify:


RESPIRATORY DIAGNOSTICS

Was a respiratory specimen collected for diagnosis:

Yes No

If yes, indicate the specimen source:


If yes, date of specimen collection:

//

If yes, record respiratory culture result

Positive Negative Result not available


If positive, report the organisms isolated from this specimen


Organism name (s): Use code list

1


2


3



This resident has documentation of provider suspected or diagnosed

Cold Pharyngitis

Influenza-like illness Lower respiratory infection

Pneumonia Other respiratory tract infection, please specify: ________________________

Enter any additional comments or information related to respiratory tract signs, symptoms or testing:






















Section D: Skin, soft tissue, bone, joint, and mucosal infection signs, symptoms, or tests

Check here if after your review NO skin, soft tissue, bone, joint, or mucosal signs, symptoms or tests are documented

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):


Pus present at the affected wound, skin, or soft tissue site


Presence of inflammation at the affected wound or skin or soft tissue site

SELECT WHICH OF THE FOLLOWING WERE DOCUMENTED:

Heat at the affected site

Redness at the affected site

Serous drainage at the affected site

Tenderness or pain at the affected site

Swelling at the affected site


A topical antibiotic was applied at affected site (e.g., ointment or cream). Name of topical agent:________________


The affected site is:________________________


CULTURE RELATED TO THE AFFECTED WOUND OR SKIN SITE

Was a wound or skin specimen collected for culture

Yes No

If yes, indicate the specimen source:


If yes, date of specimen collection:

//

If yes, record the culture result

Positive Negative Result not available

If positive, report the organisms isolated from this specimen


Organism name (s): Use code list


1



2



3




This resident has documentation of provider suspected or diagnosed

Wound infection Cellulitis Osteomyelitis Joint infection Other, please specify: ________________________

SUSPECTED SCABIES: INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

Maculopapular and/or itching rash

Laboratory confirmation (positive scraping or biopsy)

Epidemiological linkage to a case of scabies with lab confirmation

Provider diagnosis of scabies

Scabies other:___________________________


SUSPECTED FUNGAL SKIN or ORAL/PERIORAL INFECTION: INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

Presence of raises white patches in inflamed mucosa or plaques on oral mucosa

Provider diagnosis of oral candidiasis

Characteristic skin rash or skin lesion

Lab confirmed fungal pathogen from skin scraping or biopsy

Provider diagnosis of fungal skin infection

Fungal other:___________________________


SUSPECTED HERPES SIMPLEX OR ZOSTER INFECTION: INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

Vesicular rash

Laboratory confirmation of herpes simplex or herpes zoster infection

Provider diagnosis of herpes simplex

Provider diagnosis of herpes zoster infection

Herpes other:___________________________



**Section D continues on the next page**



SUSPECTED CONJUNCTIVITIS (“Pink eye”)

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

Pus appearing from one or both eyes, present for at least 24 hours

New or increased conjunctival erythema, with or without itching

New or increased conjunctival pain, present for at least 24 hours.

Topical antimicrobial applied to eyes (e.g., ointment or drops)

NO documentation that conjunctivitis symptoms (“pink eye”) symptoms are due of allergic reaction or trauma

Provider diagnosis of conjunctivitis


SUSPECTED EAR INFECTION

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

New drainage from one or both ears

Ear pain

Ear tenderness

Topical antimicrobial applied to ears (e.g., ointment or drops)

Provider diagnosis of an ear infection



Enter any additional comments or information related to skin, soft tissue, bone, joint, and mucosal infection signs, symptoms, or tests




































Section E: Gastrointestinal tract infection signs, symptoms or tests

Check here if after your review NO gastrointestinal signs, symptoms or tests are documented

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):

Diarrhea

Exceeds or equivalent to: 3 liquid or watery stools in 24-h period

Diarrhea is documented, but frequency and/or time-period not known

Vomiting

Exceeds or equivalent to: 2 episodes in 24-h period

Vomiting is documented but frequency and/or time-period not known

Nausea

Abdominal pain or tenderness

Documentation of a noninfectious cause of diarrhea, vomiting or nausea, Specify:_________________________________________________

ABDOMINAL X-RAY IMAGINING

Was X-RAY imaging performed

Yes No

If yes, date performed:

//

If yes, record the following findings


X-ray result not available

Negative x-ray findings

POSTIVE for evidence of toxic megacolon

Positive with findings not consistent with toxic megacolon

Other findings, specify:



STOOL TESTING FOR CLOSTRIDIUM DIFFICILE INFECTION

Was an order written for C. difficle testing

Yes No

If yes, order date:

//

Was stool collected for C. difficile testing:

Yes No

If yes, date of specimen collection:

//

Test type:

NAAT/PCR EIA Other (specify):___________

C. difficile test result:

Positive Negative Result not available


STOOL CULTURE FOR PATHOGENS (Bacteria, Parasite, etc.)

Was a stool specimens collected

Yes No

If yes, date of specimen collection:

//

If yes, record the culture result

Positive Negative Result not available

If positive, report the organisms isolated from this specimen


Organism name (s): Use code list



1




2




3





The resident was diagnosed with pseudomembranous colitis by endoscopy, surgery or biopsy Yes No

If yes, diagnosis date: //


The resident has documentation of provider suspected or diagnosed

C. difficile infection Gastroenteritis

Enter any additional comments or information related to gastrointestinal tract signs, symptoms, or tests







Section F: Bloodstream Infection, sepsis, blood cultures

Check here if after your review NO bloodstream infection or sepsis is documented

INDICATE WHICH OF THE FOLLOWING WERE DOCUMENTED (SELECT ALL THAT APPLY):


BLOOD CULTURE

Was blood collected for culture

Yes No

If yes, date of specimen collection:

//

Blood culture test result:

Positive Negative Result unavailable

If positive, indicate if ;

A single blood culture with a NHSN-defined recognized pathogen

Two or more blood cultures positive for the same NHSN-defined commensal organism


If positive, report the organisms isolated from this specimen



Organism name (s): Use code list

1


2


3



The resident has documentation of provider suspected or diagnosed

Bloodstream infection Sepsis


Enter any additional comments or information related to bloodstream Infection, sepsis, blood cultures











Section G: Any other infections or relevant information


















Section H: Selected Antimicrobial Susceptibilities

Check here if NO organisms were isolated or if the organism isolated if NOT one of those listed below - Data collection is now complete

If one or more of the organism listed below was isolated from a specimen collected, check the box for the organism(s) and report the susceptibility result for the indicated antimicrobial agents. If 2 or more strains of the same organism are identified, enter the susceptibility pattern for the first organism isolated (by date).



Organism name [code]

OX/METH

VANC

LINZ

TMZ


AMP

CEFZN

AMP-SUL

PIP-TAZO

CIPRO

LEVO

CEFTRX

CEFTAZ

CEFEP

GENT

IMI

MERO

S. aureus [SA]

S  

N/A

S  

N/A 

 S  



 N/A 

S  

N/A 


S  

N/A 











Enterococcus spp.

[ENTFM or ENTFS]

S  

N/A

S  

N/A

 S  



 N/A 


S  

N/A 












E. coli [EC]




S  

N/A 

S  

N/A 

S  

R

N/A

S  

R

N/A

S  

R

N/A

 S  

R

 N/A

S  

R

N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

Klebsiella pneumoniae

or oxytoca [KP or KO]



S  

N/A 

S  

N/A 

S  

R

N/A

S  

R

N/A

S  

R

N/A

 S  

 R

 N/A

S  

R

N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

Proteus mirabilis [PM]




S  

N/A 

S  

N/A 

S  

R

N/A

S  

R

N/A

S  

R

N/A

 S  

 R

 N/A

S  

R

N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

Enterobacter cloacae [ENC]




S  

N/A 

S  

N/A 

S  

R

N/A

S  

R

N/A

S  

R

N/A

 S

 R

 N/A

S  

R

N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

Pseudomonas aeruginosa [PA]








R

N/A

 S  

 R

 N/A

S  

R

N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

Acinetobacter baumanii [ACBA]







S  

R

N/A

S  

R

N/A

 S  

 R

 N/A

S  

R

N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

 S  

 R

 N/A

S – Susceptible R – Intermediate or resistance N/A – Not available or not tested


Antimicrobial agent abbreviations: AMP=ampicillin, AMP-SUL=ampicillin/sulbactam, CEFZN= cefazolin, CEFEP = cefepime, CEFTAZ=ceftazidime, CEFTRX=ceftriaxone, CIPRO = ciprofloxacin, GENT=gentamicin, IMI=imipenem, LEVO=levofloxacin, LINZ = linezolid, MERO = meropenem OX/METH=oxacillin or methicillin, PIP-TAZO=piperacillin/ tazobactam, TMZ=trimethoprim/sulfamethoxazole, VANC=vancomycin








File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorLisa La Place
File Modified0000-00-00
File Created2021-01-23

© 2024 OMB.report | Privacy Policy